Predictive accuracy of T2-FLAIR mismatch sign for the IDH-mutant, 1p/19q non-codeleted low grade glioma: an updated systematic review and meta-analysis
08:00Yoon Ah Do, Gyeonggi-do / KR
3
18 F-FLT compared to 11 C-MET positron emission tomography (PET) in the differential diagnosis between recurrent intracranial tumours and treatment-induced changes
08:00Ishita Huq, Uppsala / SE
4
Comparison of intravoxel incoherent motion imaging and dynamic susceptibility contrast perfusion in differentiating intracranial tumour recurrence from treatment-induced changes
08:00Jussi Hellström, Uppsala / SE
5
Subventricular zone involvement as an adverse prognostic factor for glioblastoma, IDH-wild type: survival model update in a brain tumour registry
08:00Ji Eun Kim, Seoul / KR
6
Magnetic resonance imaging-based risk stratification in diffuse glioma, not otherwise specified, achieves pathologic-level prognostication
08:00Eun Bee Jang, Seoul / KR
7
Multiparametric MRI for T2 FLAIR mismatch sign in IDH mutant 1p19q non-codeleted astrocytoma
08:00Jian Ping Jen, Birmingham / UK
8
Machine learning-based radiomics can distinguish between glioblastoma and metastasis
08:00Markand Patel, Birmingham / UK
9
The influence of pre- and postsurgery volumetric MRI on high grade gliomas
08:00Maria Teresa Fernandez Taranilla, Madrid / ES
10
Fast high-resolution metabolic imaging in glioma patients with non-cartesian compressed-sense MR spectroscopic imaging at 7 Tesla